BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOTBiotechnology
-$0.03 today
- Market cap
- $144.85M
- Beta
- 0.29
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$4.95
Volume 0.58M
Average 0.37M
BBOT Intangible Assets
Identifiable non-physical assets such as patents, trademarks, licenses, and customer relationships.
BridgeBio Oncology Therapeutics Inc.NASDAQ: BBOT
Intangible Assets · Q1 FY2026 · quarter ended Mar 2026
Intangible assets remains negative
Q1 FY2026 intangible assets was $0, compared with $0 a year earlier.
Context
- Intangible assets amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Intangible assets increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Intangible Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Intangible Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Intangible Assets vs competitors
How BBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so intangible assets is compared through growth and share of total assets rather than absolute size.
- Intangible assets amounts to 0.0% of total assets for BBOT, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CHF 13.25M CHF | -0.3% | +2.9% | 5.4% | |
| Jun 2026 | $6.52M USD | -42.0% | -23.2% | 0.9% | |
BBOTBridgeBio Oncology Therapeutics Inc. | Mar 2026 | $0 USD | — | — | 0.0% |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
SEPNSepterna, Inc. | Sep 2026 | $0 USD | — | — | 0.0% |
| Aug 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BBOT) | — | -21.2% | -10.1% | 0.0% | |
Competitors are the stored peer set for BBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
Intrinsic Alpha fair value
Locked
Current Price
$1.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.